Fidson Nigeria selected to produce generic influenza antiviral under global licence

Fidson Healthcare, a Nigerian drugmaker, has been selected to manufacture a generic influenza antiviral under a global licensing agreement, alongside manufacturers from Brazil, China, India, Indonesia, Malaysia, Uganda, Ukraine, and Vietnam. The move expands local production capacity for pandemic preparedness in Africa, though the specific antiviral and licence terms are not disclosed. This signals a shift toward regional manufacturing of critical medicines, reducing reliance on imports.